Gliptin Treatment Tied to Higher Risk of Acute Pancreatitis

Share this content:
Gliptin Treatment Tied to Higher Risk of Acute Pancreatitis
Gliptin Treatment Tied to Higher Risk of Acute Pancreatitis

TUESDAY, Sept. 27, 2016 (HealthDay News) -- Gliptin treatment is associated with increased acute pancreatitis risk, according to research published online Sept. 22 in Diabetes Care.

Ivan Tkac, M.D., Ph.D., from Pasteur University Hospital in Kosice, Slovakia, and Itamar Raz, M.D., from Hadassah Hebrew University Hospital in Jerusalem, combined data on the incidence of acute pancreatitis from three large randomized controlled trials designed to examine the cardiovascular safety and efficacy of add-on gliptin treatment. Data were included from SAVOR-TIMI 53 (saxagliptin), EXAMINE (alogliptin), and TECOS (sitagliptin) for 18,238 gliptin-treated patients and 18,157 placebo-treated patients.

The researchers found that gliptin-treated patients had significantly increased incidence of acute pancreatitis (odds ratio, 1.79; P = 0.013). There was a small difference in absolute risk (0.13 percent).

"Treatment with gliptins significantly increased the risk for acute pancreatitis in a combined analysis of three large controlled randomized trials," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Collaborative Care Cuts Depressive Symptoms in Seniors

Collaborative Care Cuts Depressive Symptoms in Seniors

Among older adults with subthreshold depression, collaborative care linked to decrease in PHQ-9 scores

Diet, Tobacco Counseling Feasible During Optometry Visits

Diet, Tobacco Counseling Feasible During Optometry Visits

Nearly 75% of adults surveyed indicated feeling comfortable talking to optometrist about these issues

Weight Loss of 10 Beneficial in Overweight, Not Obese, With DM

Weight Loss of 10% Beneficial in Overweight, Not ...

Five-year follow-up shows reduction in glucose-lowering medications, lower HbA1c, improved QoL

is free, fast, and customized just for you!

Already a member?

Sign In Now »